Self-deliverable RNAi (sd-rxRNAi) to Enhance T-cell Therapies in a Pre-clinical AML Model
|Effective start/end date||12/1/17 → 11/30/19|
- RXI PHARMACEUTICALS CORPORATION
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.